Glucose promotes secretion-dependent renal cyst growth (Q38838454)

6 September 2017

title

Glucose promotes secretion-dependent renal cyst growth (English)

1 reference

6 September 2017

7

Kai-Uwe Eckardt

1 reference

6 September 2017

Andre Kraus

1

1 reference

6 September 2017

Gunnar Schley

2

1 reference

6 September 2017

Karl Kunzelmann

3

1 reference

6 September 2017

Rainer Schreiber

4

1 reference

6 September 2017

Dorien J M Peters

5

1 reference

6 September 2017

Ruth Stadler

6

1 reference

6 September 2017

Bjoern Buchholz

8

1 reference

6 September 2017

publication date

3 September 2015

1 reference

Journal of Molecular Medicine

6 September 2017

published in

1 reference

6 September 2017

volume

94

1 reference

6 September 2017

issue

1

1 reference

6 September 2017

page(s)

107-117

1 reference

Autosomal dominant polycystic kidney disease

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Why kidneys fail in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Glucose stimulates calcium-activated chloride secretion in small intestinal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Everolimus in patients with autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y(13) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

CFTR is activated through stimulation of purinergic P2Y2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Purinergic P2Y6 receptors induce Ca2 and CFTR dependent Cl- secretion in mouse trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

CFTR-adenylyl cyclase I association responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Crosstalk between cAMP and Ca2 signaling in non-excitable cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Airway epithelial cells--functional links between CFTR and anoctamin dependent Cl- secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

CFTR induces extracellular acid sensing in Xenopus oocytes which activates endogenous Ca²⁺-activated Cl⁻ conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Adaptation to hypoxia in the diabetic rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Advanced glycated end-products affect HIF-transcriptional activity in renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

First diabetes prevalence study in Portugal: PREVADIAB study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Aging and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-015-1337-4

Modulation of intracellular Ca2 by glucose in MDCK cells: role of endoplasmic reticulum Ca(2 )-ATPase

21 January 2018

1 reference

12 December 2020

Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease

1 reference

12 December 2020

Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to enhance tubulogenesis.

1 reference

12 December 2020

Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na( ),K( ),2Cl(-) Co-transporter-dependent cystic dilation

1 reference

12 December 2020

10.1007/S00109-015-1337-4

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1011835676

0 references

1 reference